Public Profile

Sheffield Pharmaceuticals

Sheffield Pharmaceuticals, a prominent player in the pharmaceutical industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 1990, the company has established itself as a leader in the development and manufacturing of over-the-counter (OTC) products, including topical analgesics, wound care solutions, and dietary supplements. Sheffield Pharmaceuticals is renowned for its commitment to quality and innovation, offering unique formulations that cater to diverse consumer needs. With a strong market position, the company has achieved notable milestones, including partnerships with major retailers and a robust portfolio of trusted brands. As a result, Sheffield Pharmaceuticals continues to enhance the health and well-being of consumers worldwide.

DitchCarbon Score

How does Sheffield Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Sheffield Pharmaceuticals's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

Sheffield Pharmaceuticals's reported carbon emissions

Sheffield Pharmaceuticals currently does not have available carbon emissions data for recent years, nor do they have specified reduction targets or initiatives documented. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the company may still be engaged in industry-standard practices aimed at reducing carbon footprints and enhancing environmental responsibility. As the pharmaceutical industry increasingly focuses on sustainability, Sheffield Pharmaceuticals may align with broader climate commitments within the sector, although specific details are not provided.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sheffield Pharmaceuticals's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Sheffield Pharmaceuticals is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sheffield Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

OptimizeRx Corp

US
Health Services
Updated 4 days ago

Genesis Engineers

US
Health Services
Updated 11 days ago

Valutek Inc

US
Health Services
Updated 11 days ago

Eight Sleep

US
Health Services
Updated 11 days ago

HBJR Holdings Ltd.

CA
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers